Oct. 02, 2017Topics
2017 marks the 200th anniversary of UK specialty chemical and technology group Johnson Matthey which – back in 1817 – began as assayers, testing the purity of precious metals. In April 2017, Johnson Matthey has announced the ...
May. 24, 2017Topics
Johnson Matthey, which was founded in London in 1817, is celebrating its 200th anniversary this year. Through the constant application of new ideas and new processes, the company has built an organisation that has sustained two centuries ...
May. 23, 2017Topics
Catalysis is a key technology for sustainable manufacturing processes in the chemical industry. Catalytic processes play an important role in roughly 90% of all chemical products, from inorganic and organic basic chemicals to cosmetic ...
Apr. 24, 2017News & Opinions
UK specialty chemical and technology group Johnson Matthey has announced it is reorganizing its corporate divisions with immediate effect. It has retained four divisions but some businesses have been moved to new segments. The ...
Jan. 12, 2017Topics
Johnson Matthey announced the launch of its new online catalyst store which, according to the company, provides customers with easy access to research quantities of commercial grade ligands and catalysts, to accelerate development of ...
Apr. 20, 2016News & Opinions
Johnson Matthey, a US provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced plans to collaborate with Cambridge, UK-based small-molecule drug discovery company Domainex to ...
Apr. 05, 2016Topics
Chemical companies both large and small are more comfortable today than ever before with outsourced contract manufacturing, or tolling, as it’s commonly called. For many tolling is a first resort unless they have a proprietary ...
Apr. 04, 2016Topics
In September of 2015, Siegfried completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s active pharmaceutical ingredients (APIs).
WeylChem is one of three major platforms in the portfolio of the International Chemical Investors Group (ICIG). With its non-GMP Fine Chemicals and Custom Manufacturing businesses and annual sales of more than €650 million, the ...
Mar. 15, 2016News & Opinions
Swiss fine chemical company Dottikon is investing more than 100 million Swiss francs ($101 million) at its site in Aargau to add chemical process development and production capacities for active pharmaceutical ingredients (APIs). ...
The latest information directly via newsletter.